A PHASE I/II STUDY OF ADOPTIVE T-CELL THERAPY (ALT) AND DC VACCINATION (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HDC plus ASCR) OR NON-MYELOABLATIVE CONDITIONING (NMA) IN PATIENTS (PTS) WITH RECURRENT CENTRAL PNETS (RE-MATCH PROTOCOL)
Publication
, Conference
Gururangan, S; Grant, G; Driscoll, T; Archer, G; Herndon, J; Friedman, H; Kurtzberg, J; Bigner, D; Sampson, J; Mitchell, D
Published in: NEURO-ONCOLOGY
April 1, 2013
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
April 1, 2013
Volume
15
Start / End Page
46 / 47
Location
Fort Lauderdale, FL
Publisher
OXFORD UNIV PRESS INC
Conference Name
2nd Annual Pediatric Neuro-Oncology Basic and Translational Research Conference
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gururangan, S., Grant, G., Driscoll, T., Archer, G., Herndon, J., Friedman, H., … Mitchell, D. (2013). A PHASE I/II STUDY OF ADOPTIVE T-CELL THERAPY (ALT) AND DC VACCINATION (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HDC plus ASCR) OR NON-MYELOABLATIVE CONDITIONING (NMA) IN PATIENTS (PTS) WITH RECURRENT CENTRAL PNETS (RE-MATCH PROTOCOL). In NEURO-ONCOLOGY (Vol. 15, pp. 46–47). Fort Lauderdale, FL: OXFORD UNIV PRESS INC.
Gururangan, Sridharan, Gerald Grant, Tim Driscoll, Gerald Archer, James Herndon, Henry Friedman, Joanne Kurtzberg, Darell Bigner, John Sampson, and Duane Mitchell. “A PHASE I/II STUDY OF ADOPTIVE T-CELL THERAPY (ALT) AND DC VACCINATION (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HDC plus ASCR) OR NON-MYELOABLATIVE CONDITIONING (NMA) IN PATIENTS (PTS) WITH RECURRENT CENTRAL PNETS (RE-MATCH PROTOCOL).” In NEURO-ONCOLOGY, 15:46–47. OXFORD UNIV PRESS INC, 2013.
Gururangan S, Grant G, Driscoll T, Archer G, Herndon J, Friedman H, et al. A PHASE I/II STUDY OF ADOPTIVE T-CELL THERAPY (ALT) AND DC VACCINATION (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HDC plus ASCR) OR NON-MYELOABLATIVE CONDITIONING (NMA) IN PATIENTS (PTS) WITH RECURRENT CENTRAL PNETS (RE-MATCH PROTOCOL). In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2013. p. 46–7.
Gururangan, Sridharan, et al. “A PHASE I/II STUDY OF ADOPTIVE T-CELL THERAPY (ALT) AND DC VACCINATION (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HDC plus ASCR) OR NON-MYELOABLATIVE CONDITIONING (NMA) IN PATIENTS (PTS) WITH RECURRENT CENTRAL PNETS (RE-MATCH PROTOCOL).” NEURO-ONCOLOGY, vol. 15, OXFORD UNIV PRESS INC, 2013, pp. 46–47.
Gururangan S, Grant G, Driscoll T, Archer G, Herndon J, Friedman H, Kurtzberg J, Bigner D, Sampson J, Mitchell D. A PHASE I/II STUDY OF ADOPTIVE T-CELL THERAPY (ALT) AND DC VACCINATION (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HDC plus ASCR) OR NON-MYELOABLATIVE CONDITIONING (NMA) IN PATIENTS (PTS) WITH RECURRENT CENTRAL PNETS (RE-MATCH PROTOCOL). NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2013. p. 46–47.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
April 1, 2013
Volume
15
Start / End Page
46 / 47
Location
Fort Lauderdale, FL
Publisher
OXFORD UNIV PRESS INC
Conference Name
2nd Annual Pediatric Neuro-Oncology Basic and Translational Research Conference
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences